NCT00452387 · Interventional trial
Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)
Overall registry status Terminated
Phase 2
Conditions Metastatic Prostate Cancer
Delaware Valley sites
- Pennsylvania Oncology Hematmology Associates · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory